{"url_path":"/sec/pahc/8-k/2026-04-27/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 REGULATION FD DISCLOSURE.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-04-27","source_url":"https://www.sec.gov/Archives/edgar/data/1069899/0001104659-26-049485-index.html","accession_number":"0001104659-26-049485","cik":"0001069899","ticker":"PAHC","issuer_name":"PHIBRO ANIMAL HEALTH CORP","edgar_url":"https://www.sec.gov/Archives/edgar/data/1069899/0001104659-26-049485-index.html","primary_entity_key":"0001069899","primary_entity_name":"PHIBRO ANIMAL HEALTH CORP"},"word_count":276,"has_tables":true,"body_markdown":"**ITEM 7.01 REGULATION FD DISCLOSURE.**\n\n** **\n\nOn April 27, 2026, Phibro Animal Health Corporation (the “Company”),\nissued a press release regarding Ordinance No. 1617, published on April 27, 2026 by the Brazilian Ministry of Agriculture and Livestock\n(MAPA), prohibiting the importation, manufacture, marketing and use of performance enhancing feed additives containing antimicrobials\nclassified as important in human or veterinary medicine, including Phibro’s virginiamycin and bacitracin products. This prohibition\nwill come into effect after a transition period of 180 days from the date of the Ordinance. During such transition period, companies and\ncustomers may continue to use and sell the products under their current labels. The Company has been actively engaged with MAPA on new\nregistrations of virginiamycin for therapeutic use in cattle and broiler chickens, which are in the final stages of review and approval\nby MAPA and are expected during the transition period. The Company’s bacitracin product already carries therapeutic claims in Brazil.\nBased on the 180 day transition period, the Company expects the regulatory change to have limited impact on its fiscal year 2026 results.\nA copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.\n\n \n\nThe information contained in this Item 7.01 and in the press release\nis being furnished and shall not be deemed to be “filed” for purposes of Section 18 of, or otherwise regarded as filed under,\nthe Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall it be deemed incorporated by reference into\nany filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference\nin such filing."}